Applying Escobar, Court Rejects Comparative Effectiveness and “Fraud on the Formulary” Claims
In United States ex rel.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.